Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock

NCT07129031 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07129031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
Lead sponsor
Xijing Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
December 31, 2027
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, hemorrhagic shock, upper gastrointestinal bleeding (ugib)